🦊/Investors

BIOSPRING PARTNERS2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Labvivalabviva.cominJan 2025 · $25M✓ verified

Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs.

AI & Machine LearningBiotechEnterprise SoftwareSaaSCambridge, US

SiamakinSiamak Baharloo(Executive Officer, Director)inCarlo(GM of Europe)inNick Premnath(SVP of Commercial Strategy)inAaron Miramontes(Executive Officer)Nicholas Rioux(Executive Officer, Director)in

Co-investorsGlasswing VenturesVillage GlobalB Capital GroupB4 CapitalMassVentures53 Stations

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.